Pancreatic cancer is the 12th most common cancer in the world and remains one of the deadliest, with a five-year survival rate of only 13%, despite recent progress.

Did you know that lung cancer is the most diagnosed cancer in the world? In 2022, it accounted for 12.4% of all new cancer cases and 18.7% of deaths.

Prostate cancer is on the increase globally, especially in men under the age of 50, and in 2022 there were 1.47 million new cases.

Radiopharmaceutical therapy utilizes radioactive atoms to target and precisely treat cancer cells.

Conducting a Phase I First-In-Human (FIH) trial for Wilson’s Disease presents unique challenges due to the rarity…

Cell & Gene Therapy: Safety and Clinical Activity in Patients with Relapsed or Refractory Diffuse Large B Cell Lymphoma Case…

Aixial Group is currently collaborating with a US pharmaceutical company on a Phase II clinical trial involving paediatric patients with specific inherited metabolic disorders…

Data Science & Analytics: Combining A Phase I Study with an On-Going Observational Study Case study This case study looks…

Early Phase Oncology: First-In-Human Study Of An Antibody-Drug Conjugate In Breast Cancer Case study For a First In Human study,…

Early-Phase Oncology: First-In-Human Study in Advanced Solid Tumors Case study For a First In Human study, site activation and enrollment…

Conducting research in rare diseases like Primary Biliary Cholangitis (PBC) presents unique challenges due to limited precedents and small patient population.

Efficient Publication Strategy Leads to Expedited Submission and Acceptance Case study Since the World Health Organization (WHO) launched the Global…